SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice - Volosnikova, Ekaterina A.; Merkuleva, Iuliia A.; Esina, Tatiana I.; Shcherbakov, Dmitry N.; Borgoyakova, Mariya B.; Isaeva, Anastasiya A.; Nesmeyanova, Valentina S.; Volkova, Natalia V.; Belenkaya, Svetlana V.; Zaykovskaya, Anna V.; Pyankov, Oleg V.; Starostina, Ekaterina V.; et al. (Vaccines (Basel), 2023)
Keywords: adjuvant; Adjuvants; Aluminum; Animals; Antibodies; Antibody-drug conjugates; Antigens; CD4 antigen; CD8 antigen; Cloning; Comparative analysis; Coronaviruses; COVID-19; COVID-19 vaccines; Dosage and administration; Double-stranded RNA; Immune response; Immune response (humoral); Immune system; Immunization; Immunogenicity; Immunoglobulin G; Laboratory animals; Lymphocytes; Lymphocytes T; Nanoparticles; Neutralizing; Polyamines; Proteins; RBD; receptor-binding domain; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Spermidine; Spike protein; Testing; Vaccines; Vectors (Biology); Viral diseases; Yeast; Russia; United States--US; Germany; COVID-19; SARS-CoV-2; RBD; adjuvant; receptor-binding domain